Medicure (MCUJF) Cash from Investing Activities (2010 - 2026)

Medicure's Cash from Investing Activities history runs 15 years deep, the most recent figure standing at -$278556.6 for Q1 2026.

• On a quarterly basis, Cash from Investing Activities rose 26.25% year-over-year to -$278556.6 in Q1 2026; TTM through Mar 2026 was -$1.4 million, a 60.63% decrease from a year earlier, with the FY2025 full-year figure at -$1.5 million, down 170.77% from the prior year.
• Cash from Investing Activities eased to -$278556.6 in Q1 2026 per MCUJF's latest filing, from $96806.6 in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $96806.6 in Q4 2025 and bottomed at -$1.2 million in Q2 2025.
• The 5-year median for Cash from Investing Activities is -$89901.3 (2023), against an average of -$203051.1.
• Biggest YoY gain for Cash from Investing Activities was 130.19% in 2025; the steepest drop was 1451.84% in 2025.
• Year by year, Cash from Investing Activities stood at -$206254.7 in 2022, then soared by 54.42% to -$94020.5 in 2023, then plunged by 241.1% to -$320700.4 in 2024, then soared by 130.19% to $96806.6 in 2025, then tumbled by 387.75% to -$278556.6 in 2026.
• Per Business Quant, the three latest MCUJF Cash from Investing Activities figures stand at -$278556.6 (Q1 2026), $96806.6 (Q4 2025), and -$1.2 million (Q2 2025).